Reactions 1704, p19 - 2 Jun 2018 Sarcoid-like granulomatosis: case report A 17-year-old boy developed paradoxical sarcoid-like granulomatosis during treatment with etanercept and adalimumab [routes and dosages not stated] for psoriasis. The boy, who had been diagnosed with psoriasis at the age of 3, had received unspecified steroids in the past. He presented with abdominal pain, fatigue and weight loss. He had received etanercept for 2 years followed by adalimumab for the past year before this presentation. An abdominal CT scan showed lymphadenopathy. A positron emission tomography (PET)/CT scan showed hyper-metabolic diffuse lymphadenopathy involving neck, chest, retroperitoneal and mesenteric lymph nodes. An axillary lymph node biopsy demonstrated numerous, epithelioid and non-ceseating coalescing granulomas with multi-nucleated giant-cells. The boy’s treatment with adalimumab was stopped. Eventually, he recovered. Author comment: "This case illustrates the rare, paradoxical adverse effect of sarcoid-like granulomatosis in patients treated with anti-TNFa for chronic inflammatory diseases." Leventaki V, et al. Sarcoid-like granulomatosis in a patient receiving anti- TNFalpha for psoriasis. American Journal of Hematology 93: 722-723, No. 5, May 2018. Available from: URL: http://doi.org/10.1002/ajh.25021 - USA 803322760 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera